nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—SLC6A4—chronic obstructive pulmonary disease	0.331	0.655	CbGaD
Pethidine—ALB—chronic obstructive pulmonary disease	0.174	0.345	CbGaD
Pethidine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0428	0.133	CbGbCtD
Pethidine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0428	0.133	CbGbCtD
Pethidine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0325	0.101	CbGbCtD
Pethidine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0325	0.101	CbGbCtD
Pethidine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.029	0.09	CbGbCtD
Pethidine—ALB—Prednisone—chronic obstructive pulmonary disease	0.0277	0.086	CbGbCtD
Pethidine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0273	0.0847	CbGbCtD
Pethidine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0184	0.0572	CbGbCtD
Pethidine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.018	0.0558	CbGbCtD
Pethidine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0176	0.0546	CbGbCtD
Pethidine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0157	0.0487	CbGbCtD
Pethidine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00919	0.0286	CbGbCtD
Pethidine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00868	0.027	CbGbCtD
Pethidine—Milnacipran—SLC6A4—chronic obstructive pulmonary disease	0.00188	0.635	CrCbGaD
Pethidine—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.0096	CcSEcCtD
Pethidine—Levomilnacipran—SLC6A4—chronic obstructive pulmonary disease	0.00108	0.365	CrCbGaD
Pethidine—Withdrawal syndrome—Prednisone—chronic obstructive pulmonary disease	0.000981	0.00848	CcSEcCtD
Pethidine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.000948	0.00819	CcSEcCtD
Pethidine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.000945	0.00816	CcSEcCtD
Pethidine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.000891	0.0077	CcSEcCtD
Pethidine—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00089	0.00769	CcSEcCtD
Pethidine—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00088	0.0076	CcSEcCtD
Pethidine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000862	0.00745	CcSEcCtD
Pethidine—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.000858	0.00741	CcSEcCtD
Pethidine—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.000845	0.0073	CcSEcCtD
Pethidine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00084	0.00726	CcSEcCtD
Pethidine—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.000828	0.00715	CcSEcCtD
Pethidine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000806	0.00696	CcSEcCtD
Pethidine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000793	0.00685	CcSEcCtD
Pethidine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000761	0.00658	CcSEcCtD
Pethidine—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.000707	0.00611	CcSEcCtD
Pethidine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000707	0.00611	CcSEcCtD
Pethidine—Affect lability—Salbutamol—chronic obstructive pulmonary disease	0.000703	0.00607	CcSEcCtD
Pethidine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00589	CcSEcCtD
Pethidine—Mood swings—Salbutamol—chronic obstructive pulmonary disease	0.000676	0.00584	CcSEcCtD
Pethidine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000662	0.00572	CcSEcCtD
Pethidine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.000638	0.00551	CcSEcCtD
Pethidine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000636	0.0055	CcSEcCtD
Pethidine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000626	0.00541	CcSEcCtD
Pethidine—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000625	0.0054	CcSEcCtD
Pethidine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000603	0.00521	CcSEcCtD
Pethidine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000582	0.00503	CcSEcCtD
Pethidine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000571	0.00493	CcSEcCtD
Pethidine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00056	0.00484	CcSEcCtD
Pethidine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00475	CcSEcCtD
Pethidine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00055	0.00475	CcSEcCtD
Pethidine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000539	0.00466	CcSEcCtD
Pethidine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000529	0.00457	CcSEcCtD
Pethidine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00456	CcSEcCtD
Pethidine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000525	0.00454	CcSEcCtD
Pethidine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000518	0.00448	CcSEcCtD
Pethidine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00051	0.0044	CcSEcCtD
Pethidine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000508	0.00439	CcSEcCtD
Pethidine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000506	0.00437	CcSEcCtD
Pethidine—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000504	0.00436	CcSEcCtD
Pethidine—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000504	0.00436	CcSEcCtD
Pethidine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000499	0.00431	CcSEcCtD
Pethidine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000496	0.00428	CcSEcCtD
Pethidine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000488	0.00422	CcSEcCtD
Pethidine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000487	0.00421	CcSEcCtD
Pethidine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000485	0.00419	CcSEcCtD
Pethidine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000484	0.00418	CcSEcCtD
Pethidine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00048	0.00415	CcSEcCtD
Pethidine—Delirium—Prednisone—chronic obstructive pulmonary disease	0.000477	0.00412	CcSEcCtD
Pethidine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000477	0.00412	CcSEcCtD
Pethidine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00047	0.00406	CcSEcCtD
Pethidine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000465	0.00402	CcSEcCtD
Pethidine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000465	0.00402	CcSEcCtD
Pethidine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000462	0.00399	CcSEcCtD
Pethidine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000461	0.00399	CcSEcCtD
Pethidine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00046	0.00398	CcSEcCtD
Pethidine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000459	0.00396	CcSEcCtD
Pethidine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00396	CcSEcCtD
Pethidine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000456	0.00394	CcSEcCtD
Pethidine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000453	0.00391	CcSEcCtD
Pethidine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000449	0.00388	CcSEcCtD
Pethidine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.00382	CcSEcCtD
Pethidine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.00378	CcSEcCtD
Pethidine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000438	0.00378	CcSEcCtD
Pethidine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000435	0.00376	CcSEcCtD
Pethidine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000432	0.00373	CcSEcCtD
Pethidine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000429	0.00371	CcSEcCtD
Pethidine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000427	0.00369	CcSEcCtD
Pethidine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000427	0.00369	CcSEcCtD
Pethidine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000424	0.00367	CcSEcCtD
Pethidine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.00362	CcSEcCtD
Pethidine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000418	0.00362	CcSEcCtD
Pethidine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00361	CcSEcCtD
Pethidine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000416	0.0036	CcSEcCtD
Pethidine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00357	CcSEcCtD
Pethidine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00354	CcSEcCtD
Pethidine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000403	0.00348	CcSEcCtD
Pethidine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00348	CcSEcCtD
Pethidine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00348	CcSEcCtD
Pethidine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00348	CcSEcCtD
Pethidine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00341	CcSEcCtD
Pethidine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000394	0.00341	CcSEcCtD
Pethidine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000394	0.0034	CcSEcCtD
Pethidine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.0034	CcSEcCtD
Pethidine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000393	0.0034	CcSEcCtD
Pethidine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000389	0.00336	CcSEcCtD
Pethidine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.00335	CcSEcCtD
Pethidine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000388	0.00335	CcSEcCtD
Pethidine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00334	CcSEcCtD
Pethidine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00334	CcSEcCtD
Pethidine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00334	CcSEcCtD
Pethidine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00334	CcSEcCtD
Pethidine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00333	CcSEcCtD
Pethidine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00328	CcSEcCtD
Pethidine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00328	CcSEcCtD
Pethidine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00328	CcSEcCtD
Pethidine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00327	CcSEcCtD
Pethidine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.00327	CcSEcCtD
Pethidine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00321	CcSEcCtD
Pethidine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00321	CcSEcCtD
Pethidine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00321	CcSEcCtD
Pethidine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00321	CcSEcCtD
Pethidine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00321	CcSEcCtD
Pethidine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000366	0.00316	CcSEcCtD
Pethidine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00315	CcSEcCtD
Pethidine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00315	CcSEcCtD
Pethidine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00315	CcSEcCtD
Pethidine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00313	CcSEcCtD
Pethidine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00313	CcSEcCtD
Pethidine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.00311	CcSEcCtD
Pethidine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00309	CcSEcCtD
Pethidine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000357	0.00309	CcSEcCtD
Pethidine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000352	0.00304	CcSEcCtD
Pethidine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00303	CcSEcCtD
Pethidine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00303	CcSEcCtD
Pethidine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000347	0.003	CcSEcCtD
Pethidine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.003	CcSEcCtD
Pethidine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000345	0.00299	CcSEcCtD
Pethidine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00298	CcSEcCtD
Pethidine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00296	CcSEcCtD
Pethidine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000339	0.00293	CcSEcCtD
Pethidine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00293	CcSEcCtD
Pethidine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000336	0.0029	CcSEcCtD
Pethidine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.0029	CcSEcCtD
Pethidine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00289	CcSEcCtD
Pethidine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00285	CcSEcCtD
Pethidine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00285	CcSEcCtD
Pethidine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00284	CcSEcCtD
Pethidine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00283	CcSEcCtD
Pethidine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000326	0.00282	CcSEcCtD
Pethidine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000324	0.0028	CcSEcCtD
Pethidine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000323	0.00279	CcSEcCtD
Pethidine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00275	CcSEcCtD
Pethidine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00275	CcSEcCtD
Pethidine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00274	CcSEcCtD
Pethidine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.0027	CcSEcCtD
Pethidine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.00268	CcSEcCtD
Pethidine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.00266	CcSEcCtD
Pethidine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.00266	CcSEcCtD
Pethidine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00265	CcSEcCtD
Pethidine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00265	CcSEcCtD
Pethidine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000306	0.00264	CcSEcCtD
Pethidine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00264	CcSEcCtD
Pethidine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000304	0.00263	CcSEcCtD
Pethidine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00259	CcSEcCtD
Pethidine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.00255	CcSEcCtD
Pethidine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000295	0.00255	CcSEcCtD
Pethidine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000293	0.00253	CcSEcCtD
Pethidine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00253	CcSEcCtD
Pethidine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000291	0.00251	CcSEcCtD
Pethidine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.00251	CcSEcCtD
Pethidine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.00251	CcSEcCtD
Pethidine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00029	0.00251	CcSEcCtD
Pethidine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000289	0.0025	CcSEcCtD
Pethidine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.0025	CcSEcCtD
Pethidine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000288	0.00249	CcSEcCtD
Pethidine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.00249	CcSEcCtD
Pethidine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00245	CcSEcCtD
Pethidine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000283	0.00244	CcSEcCtD
Pethidine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000282	0.00244	CcSEcCtD
Pethidine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00241	CcSEcCtD
Pethidine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00237	CcSEcCtD
Pethidine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00237	CcSEcCtD
Pethidine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000273	0.00236	CcSEcCtD
Pethidine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.00236	CcSEcCtD
Pethidine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00232	CcSEcCtD
Pethidine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.0023	CcSEcCtD
Pethidine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000267	0.0023	CcSEcCtD
Pethidine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000263	0.00227	CcSEcCtD
Pethidine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.00227	CcSEcCtD
Pethidine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000261	0.00226	CcSEcCtD
Pethidine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00223	CcSEcCtD
Pethidine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00223	CcSEcCtD
Pethidine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00218	CcSEcCtD
Pethidine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00215	CcSEcCtD
Pethidine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00213	CcSEcCtD
Pethidine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00212	CcSEcCtD
Pethidine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00212	CcSEcCtD
Pethidine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00208	CcSEcCtD
Pethidine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00204	CcSEcCtD
Pethidine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00204	CcSEcCtD
Pethidine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00202	CcSEcCtD
Pethidine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00202	CcSEcCtD
Pethidine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00202	CcSEcCtD
Pethidine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00202	CcSEcCtD
Pethidine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00201	CcSEcCtD
Pethidine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00201	CcSEcCtD
Pethidine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00201	CcSEcCtD
Pethidine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000231	0.002	CcSEcCtD
Pethidine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000229	0.00198	CcSEcCtD
Pethidine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000229	0.00198	CcSEcCtD
Pethidine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000228	0.00197	CcSEcCtD
Pethidine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00193	CcSEcCtD
Pethidine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.00191	CcSEcCtD
Pethidine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00191	CcSEcCtD
Pethidine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.00191	CcSEcCtD
Pethidine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00191	CcSEcCtD
Pethidine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00191	CcSEcCtD
Pethidine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00191	CcSEcCtD
Pethidine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.0019	CcSEcCtD
Pethidine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.00187	CcSEcCtD
Pethidine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000216	0.00187	CcSEcCtD
Pethidine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.00185	CcSEcCtD
Pethidine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.00184	CcSEcCtD
Pethidine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00021	0.00181	CcSEcCtD
Pethidine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.0018	CcSEcCtD
Pethidine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00177	CcSEcCtD
Pethidine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00174	CcSEcCtD
Pethidine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00174	CcSEcCtD
Pethidine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.00171	CcSEcCtD
Pethidine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.0017	CcSEcCtD
Pethidine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00168	CcSEcCtD
Pethidine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00165	CcSEcCtD
Pethidine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00157	CcSEcCtD
Pethidine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00155	CcSEcCtD
Pethidine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00143	CcSEcCtD
Pethidine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00142	CcSEcCtD
Pethidine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00139	CcSEcCtD
Pethidine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00139	CcSEcCtD
Pethidine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.00138	CcSEcCtD
Pethidine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00136	CcSEcCtD
Pethidine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00134	CcSEcCtD
Pethidine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00134	CcSEcCtD
Pethidine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00131	CcSEcCtD
Pethidine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00128	CcSEcCtD
Pethidine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00126	CcSEcCtD
Pethidine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00126	CcSEcCtD
Pethidine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00124	CcSEcCtD
Pethidine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00123	CcSEcCtD
Pethidine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00122	CcSEcCtD
Pethidine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.0012	CcSEcCtD
Pethidine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00115	CcSEcCtD
Pethidine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00114	CcSEcCtD
Pethidine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000127	0.0011	CcSEcCtD
Pethidine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.0011	CcSEcCtD
Pethidine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.0011	CcSEcCtD
Pethidine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00109	CcSEcCtD
Pethidine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00108	CcSEcCtD
Pethidine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00104	CcSEcCtD
Pethidine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.00103	CcSEcCtD
Pethidine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000116	0.001	CcSEcCtD
Pethidine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000931	CcSEcCtD
Pethidine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000907	CcSEcCtD
Pethidine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000894	CcSEcCtD
Pethidine—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.000836	CcSEcCtD
Pethidine—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.000803	CcSEcCtD
Pethidine—Rash—Prednisone—chronic obstructive pulmonary disease	9.22e-05	0.000797	CcSEcCtD
Pethidine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.21e-05	0.000796	CcSEcCtD
Pethidine—Headache—Prednisone—chronic obstructive pulmonary disease	9.16e-05	0.000792	CcSEcCtD
Pethidine—Nausea—Prednisone—chronic obstructive pulmonary disease	8.69e-05	0.000751	CcSEcCtD
Pethidine—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.36e-05	0.000982	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	5.32e-05	0.000973	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.31e-05	0.000972	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.29e-05	0.000969	CbGpPWpGaD
Pethidine—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.29e-05	0.000968	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	5.26e-05	0.000962	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.26e-05	0.000962	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—LEP—chronic obstructive pulmonary disease	5.2e-05	0.000951	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.13e-05	0.000939	CbGpPWpGaD
Pethidine—SLC6A4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.12e-05	0.000937	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—LEP—chronic obstructive pulmonary disease	5.07e-05	0.000927	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.06e-05	0.000927	CbGpPWpGaD
Pethidine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.06e-05	0.000926	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.02e-05	0.000919	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.88e-05	0.000893	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.88e-05	0.000893	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.82e-05	0.000882	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	4.79e-05	0.000877	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.75e-05	0.000869	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.72e-05	0.000864	CbGpPWpGaD
Pethidine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.65e-05	0.000852	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.6e-05	0.000842	CbGpPWpGaD
Pethidine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.59e-05	0.00084	CbGpPWpGaD
Pethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.59e-05	0.00084	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	4.59e-05	0.00084	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.54e-05	0.00083	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	4.49e-05	0.000822	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.48e-05	0.000821	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.45e-05	0.000814	CbGpPWpGaD
Pethidine—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.4e-05	0.000806	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.39e-05	0.000804	CbGpPWpGaD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.39e-05	0.000803	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.38e-05	0.000801	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	4.32e-05	0.00079	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.28e-05	0.000783	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.28e-05	0.000783	CbGpPWpGaD
Pethidine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.28e-05	0.000783	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.27e-05	0.000782	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.27e-05	0.000781	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.25e-05	0.000777	CbGpPWpGaD
Pethidine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.22e-05	0.000772	CbGpPWpGaD
Pethidine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.22e-05	0.000772	CbGpPWpGaD
Pethidine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.05e-05	0.000742	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.04e-05	0.000739	CbGpPWpGaD
Pethidine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4e-05	0.000732	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.99e-05	0.00073	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.93e-05	0.00072	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.93e-05	0.00072	CbGpPWpGaD
Pethidine—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.9e-05	0.000714	CbGpPWpGaD
Pethidine—SLC6A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.9e-05	0.000714	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.9e-05	0.000714	CbGpPWpGaD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.89e-05	0.000711	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.89e-05	0.000711	CbGpPWpGaD
Pethidine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.88e-05	0.00071	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.87e-05	0.000708	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.83e-05	0.000701	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.79e-05	0.000694	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.76e-05	0.000688	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.73e-05	0.000682	CbGpPWpGaD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.72e-05	0.00068	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.71e-05	0.00068	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.71e-05	0.00068	CbGpPWpGaD
Pethidine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.68e-05	0.000673	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.66e-05	0.00067	CbGpPWpGaD
Pethidine—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3.63e-05	0.000665	CbGpPWpGaD
Pethidine—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	3.58e-05	0.000655	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.57e-05	0.000652	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.54e-05	0.000648	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.45e-05	0.000631	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.44e-05	0.000629	CbGpPWpGaD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.41e-05	0.000624	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.41e-05	0.000624	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.37e-05	0.000617	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.36e-05	0.000614	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.31e-05	0.000606	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.29e-05	0.000602	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.26e-05	0.000597	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.26e-05	0.000597	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.18e-05	0.000581	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.15e-05	0.000576	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.12e-05	0.000572	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.1e-05	0.000567	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.05e-05	0.000557	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.01e-05	0.000551	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3e-05	0.000549	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.99e-05	0.000547	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.96e-05	0.000541	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.88e-05	0.000528	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.86e-05	0.000523	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.85e-05	0.000521	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.84e-05	0.00052	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.81e-05	0.000514	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.8e-05	0.000512	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.78e-05	0.000509	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.76e-05	0.000505	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.74e-05	0.000501	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—IL6—chronic obstructive pulmonary disease	2.72e-05	0.000498	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.72e-05	0.000497	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.71e-05	0.000497	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.68e-05	0.000491	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.65e-05	0.000485	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—IL6—chronic obstructive pulmonary disease	2.65e-05	0.000485	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.59e-05	0.000474	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.59e-05	0.000473	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.58e-05	0.000472	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.58e-05	0.000471	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.57e-05	0.000471	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.54e-05	0.000464	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.53e-05	0.000462	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.52e-05	0.000461	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.51e-05	0.000459	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.5e-05	0.000458	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.48e-05	0.000454	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.46e-05	0.00045	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.44e-05	0.000446	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.44e-05	0.000446	CbGpPWpGaD
Pethidine—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.41e-05	0.00044	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.4e-05	0.00044	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.4e-05	0.00044	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.4e-05	0.000439	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.39e-05	0.000437	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.39e-05	0.000437	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.34e-05	0.000429	CbGpPWpGaD
Pethidine—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.34e-05	0.000428	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.33e-05	0.000426	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.3e-05	0.00042	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.29e-05	0.00042	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.26e-05	0.000413	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.23e-05	0.000408	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.18e-05	0.000399	CbGpPWpGaD
Pethidine—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.18e-05	0.000398	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.16e-05	0.000395	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.000392	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.1e-05	0.000385	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.1e-05	0.000384	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.99e-05	0.000364	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.99e-05	0.000363	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.98e-05	0.000362	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.96e-05	0.000359	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.95e-05	0.000358	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.94e-05	0.000355	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.93e-05	0.000354	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.91e-05	0.000349	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.89e-05	0.000346	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.87e-05	0.000342	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.85e-05	0.000338	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.8e-05	0.000329	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.73e-05	0.000317	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.73e-05	0.000317	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.71e-05	0.000313	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.7e-05	0.000312	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.68e-05	0.000307	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.68e-05	0.000307	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.59e-05	0.000291	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.56e-05	0.000286	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.000285	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.54e-05	0.000282	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.53e-05	0.000281	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.52e-05	0.000279	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.52e-05	0.000278	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.5e-05	0.000275	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.44e-05	0.000264	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.39e-05	0.000255	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.38e-05	0.000253	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.37e-05	0.000251	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.33e-05	0.000244	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.3e-05	0.000238	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.3e-05	0.000237	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.3e-05	0.000237	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.29e-05	0.000236	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.28e-05	0.000234	CbGpPWpGaD
Pethidine—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.26e-05	0.000231	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.26e-05	0.000231	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.26e-05	0.000231	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.24e-05	0.000227	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.24e-05	0.000227	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.18e-05	0.000215	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.17e-05	0.000215	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.17e-05	0.000214	CbGpPWpGaD
Pethidine—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.15e-05	0.000211	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.15e-05	0.00021	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.13e-05	0.000208	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.13e-05	0.000206	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.06e-05	0.000195	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000194	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000193	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.05e-05	0.000193	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.05e-05	0.000192	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000191	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.04e-05	0.00019	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	0.00019	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.02e-05	0.000186	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.72e-06	0.000178	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.68e-06	0.000177	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.54e-06	0.000175	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.52e-06	0.000174	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.28e-06	0.00017	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.17e-06	0.000168	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	8.92e-06	0.000163	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.86e-06	0.000162	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.78e-06	0.000161	CbGpPWpGaD
Pethidine—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.74e-06	0.00016	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.61e-06	0.000158	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.23e-06	0.000151	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.21e-06	0.00015	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.19e-06	0.00015	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.15e-06	0.000149	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.96e-06	0.000146	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.85e-06	0.000144	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.84e-06	0.000144	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.83e-06	0.000143	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.72e-06	0.000141	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.44e-06	0.000136	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.32e-06	0.000134	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.31e-06	0.000134	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.22e-06	0.000132	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.96e-06	0.000127	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.93e-06	0.000127	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.9e-06	0.000126	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.82e-06	0.000125	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	6.74e-06	0.000123	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.73e-06	0.000123	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.68e-06	0.000122	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.61e-06	0.000121	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.38e-06	0.000117	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.29e-06	0.000115	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	6.24e-06	0.000114	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.23e-06	0.000114	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.14e-06	0.000112	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.02e-06	0.00011	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.97e-06	0.000109	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.74e-06	0.000105	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.65e-06	0.000103	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.19e-06	9.49e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.08e-06	9.3e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.05e-06	9.24e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	5.02e-06	9.19e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.79e-06	8.76e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.72e-06	8.64e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.71e-06	8.62e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.62e-06	8.46e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.51e-06	8.25e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.4e-06	8.05e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.33e-06	7.93e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.27e-06	7.81e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.17e-06	7.63e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.15e-06	7.59e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.91e-06	7.15e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.83e-06	5.19e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.71e-06	4.96e-05	CbGpPWpGaD
